GSTM2 and breast neoplasm: The expression of the tumor suppressor gene superoxide dismutase 3 (SOD3) and glutathione S-transferase Mu 2 (GSTM2) has been implicated in aggressive, high-grade breast tumors, where promoter hypermethylation is associated with poor survival in patients [237].